ClinicalTrials.gg
TerminatedNCT03548870proTENSUpdated Jan 21, 2026

Transcutaneous Electrical Nerve Stimulation During Exercise in Patients With COPD

An interventional study of CWRT with low frequency transcutaneous electrical nerve stimulation and CWRT with sham-low frequency transcutaneous electrical nerve stimulation in COPD, Physical Activity and Rehabilitation, sponsored by Groupe Hospitalier du Havre. Terminated at 1 site in France. Open to participants aged 35 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by Groupe Hospitalier du Havre · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
not enough recruitment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Ages
35 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre — 3 open to participants now, 3 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Groupe Hospitalier du Havre.

Started
2021
the only one that year
No phase
5 of 10
1 open now
Registered
2nd of 10
by date

Among the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre, this one is the only one that started in 2021, is one of 5 with no phase, and was the 2nd registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

3 of the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 35 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre, or all of them as a file.
02

Study summary

Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. Several studies showed that transcutaneous electrical nerve stimulation (TENS) could improve dyspnea and pulmonary function. The aim of this study is to assess the acute effect of TENS on exercise tolerance in post-exacerbation COPD patients

03

Conditions studied

  • COPD
  • Physical Activity
  • Rehabilitation
  • TEN
04

Who can participate

Ages eligible
35 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • a diagnosis of

Exclusion criteria

Exclusion Criteria:

  • exercise Any musculoskeletal problems, cardiovascular or
  • neurological comorbidities that limits exercise.
  • pH \< 7,35
  • Body temperature > 38°C
  • cardiac frequency > 100 bpm at rest
  • systolic blood pressure \< 100 mmHg
  • exacerbation during the study
  • heart pace-maker or defibrillator
  • Opiate treatment during the last 3 months
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
2 participants (actual)

Study arms

  • Experimental
    Test with TENS

    Patients will perform one Constant Work-Rate Exercise Test at 80% of maximum workload with low frequency TENS

    Other: CWRT with low frequency transcutaneous electrical nerve stimulation

  • Sham comparator
    Test with sham-TENS

    Patients will perform one Constant Work-Rate Exercise Test at 80% of maximum workload with low frequency sham-TENS

    Other: CWRT with sham-low frequency transcutaneous electrical nerve stimulation

Interventions

  • OtherCWRT with low frequency transcutaneous electrical nerve stimulation

    4 self adhesive surface electrodes will be positioned by pair on quadriceps. Patients will have a low frequency TENS for 20 min at rest. During this period, intensity will be increased every 5 minutes to the maximum tolerated by the patient (below pain threshold, sensation strong but comfortable). Thereafter, intensity is not increased anymore during the test. Current characteristics : Rehab 400, CefarCompex 5Hz 200 µs frequency bidirectional

  • OtherCWRT with sham-low frequency transcutaneous electrical nerve stimulation

    4 self adhesive surface electrodes are positioned by pair on quadriceps. Patients will have a sham-low frequency TENS for 20 min at rest. During this period, intensity will be increased for 1 minute to the maximum tolerated by the patient. After this procedure, intensity will be progressively setted back to 1mA. Current characteristics : Rehab 400, CefarCompex 5Hz 200 µs frequency bidirectional

06

What researchers measure

Primary outcomes

  1. comparison of exercise tolerance

    Comparison of endurance time (Tlim, in second) during constant workload testing (CWRET) under 2 conditions

    Time frame: two CWRET will be carried out in different days, separate from 24 hours minimum for a total time frame of 5 days maximum

Secondary outcomes

  1. Difference in peripheral muscle oxygenation

    Muscle oxygenation (arbitrary unit) will be evaluated using Near-infrared spectroscopy technology.

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  2. Difference in Dyspnea

    Difference in dyspnea using Modified Borg Scale (0 - 10 points) 0=no dyspnea ; 10 = maximal effort

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  3. Difference in Oxygen Saturation

    Difference in Oxygen Saturation (%) using a pulse oximetry (SpO2)

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  4. Difference in Cardiac Frequency

    Difference in Cardiac Frequence (bpm) using a pulse oximetry

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  5. Difference in muscular fatigue

    Difference in muscular fatigue using Modified Borg Scale (0 - 10 points) 0=no muscular fatigue ; 10 = maximal effort

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  6. Difference in oxygen consumption

    Difference in oxygen consumption (milliliters per minute) will be measured breath-by-breath using a computer-based exercise system

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  7. Difference in carbon dioxide production

    Difference in carbon dioxide production (milliliters per minute) will be measured breath-by-breath using a computer-based exercise system

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  8. Difference in minute ventilation

    Difference in minute ventilation (liters per minute) will be measured breath-by-breath using a computer-based exercise system

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  9. Difference in tidal volume

    Difference in tidal volume (Liters) will be measured breath-by-breath using a computer-based exercise system

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  10. Difference in respiratory rate

    Difference in respiratory rate (cycles per minute) will be measured breath-by-breath using a computer-based exercise system

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  11. Difference in inspiratory capacity

    Difference in inspiratory capacity (Liters) will be measured breath-by-breath using a computer-based exercise system

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

  12. Difference in respiratory quotient

    Difference in respiratory quotient (ratio) will be measured breath-by-breath using a computer-based exercise system

    Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise

07

Study locations

1 site
  • Groupe hospitalier du Havre
    Montivilliers, 76290, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2021 to primary completion in Oct 2023, 23 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 17, 2018
First posted
Jun 7, 2018
StartActual
Oct 23, 2021
Primary completionActual
Oct 8, 2023
CompletionActual
Oct 8, 2024
Last update
Jan 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03548870
Lead sponsor
Groupe Hospitalier du Havre
Responsible party
Sponsor
First posted
Jun 7, 2018
Start date
Oct 23, 2021
Primary completion
Oct 8, 2023
Completion
Oct 8, 2024
Last update
Jan 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion